Brief: Telesis Bio Q2 revenue USD 8.7 million
10/08/2023 22:41
Aug 10 (Reuters) - Telesis Bio Q2 net income USD -8.3 million. * Q2 gross margin 65.8% * Q2 operating expenses USD 13.7 million * Q2 revenue USD 8.7 million
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview